1-20 of 89
Razelle Kurzrock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy

Jessica Jou, Shumei Kato, Hirotaka Miyashita, Kartheeswaran Thangathurai, Sarabjot Pabla, Paul DePietro, Mary K. Nesline, Jeffrey M. Conroy, Eitan Rubin, Ramez N. Eskander, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther MCT-23-0270.
https://doi.org/10.1158/1535-7163.MCT-23-0270
Published: 25 August 2023
View article titled, Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy
Open the PDF for Cancer immunity marker RNA expression levels across gynecologic cancers: Implications for immunotherapy in another window
Includes: Supplementary data
Journal Articles

JAK: Not Just Another Kinase

Ruchi P. Agashe, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1757–1764.
https://doi.org/10.1158/1535-7163.MCT-22-0323
Published: 02 December 2022
View article titled, JAK: Not Just Another Kinase
Open the PDF for JAK: Not Just Another Kinase in another window
Journal Articles

Variable Mutation Expression in Human Cancers: A “Hide-and-Seek” Mechanism Linked to Differential MHC-I Presentation Dynamics

Amélie Boichard, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (7): 1219–1226.
https://doi.org/10.1158/1535-7163.MCT-21-0831
Published: 05 July 2022
View article titled, Variable Mutation Expression in Human Cancers: A “Hide-and-Seek” Mechanism Linked to Differential MHC-I Presentation Dynamics
Open the PDF for Variable Mutation Expression in Human Cancers: A “Hide-and-Seek” Mechanism Linked to Differential MHC-I Presentation Dynamics in another window
Includes: Supplementary data
Journal Articles

SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy

Kristina Mardinian, Jacob J. Adashek, Gregory P. Botta, Shumei Kato, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12): 2341–2351.
https://doi.org/10.1158/1535-7163.MCT-21-0433
Published: 03 December 2021
View article titled, <em>SMARCA4</em>: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy
Open the PDF for <em>SMARCA4</em>: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy in another window
Journal Articles

Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible

Taylor J. Jensen, Aaron M. Goodman, Christopher K. Ellison, Kimberly A. Holden, Shumei Kato, Lisa Kim, Gregory A. Daniels, Kerry Fitzgerald, Erin McCarthy, Prachi Nakashe, Amin R. Mazloom, Eyad Almasri, Graham McLennan, Daniel S. Grosu, Marcia Eisenberg, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (11): 2274–2279.
https://doi.org/10.1158/1535-7163.MCT-20-1066
Published: 01 November 2021
View article titled, Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible
Open the PDF for Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible in another window
Journal Articles

BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes

Mina Nikanjam, Jose Tinajero, Donald A. Barkauskas, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (6): 1072–1079.
https://doi.org/10.1158/1535-7163.MCT-20-0861
Published: 01 June 2021
View article titled, <em>BRAF</em> V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes
Open the PDF for <em>BRAF</em> V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes in another window
Journal Articles

Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA TP53 Mutations—A Perspective from a Real-World Precision Medicine Cohort

Shai Rosenberg, Ryosuke Okamura, Shumei Kato, Thierry Soussi, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (12): 2612–2620.
https://doi.org/10.1158/1535-7163.MCT-20-0097
Published: 02 December 2020
View article titled, Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA <em>TP53</em> Mutations—A Perspective from a Real-World Precision Medicine Cohort
Open the PDF for Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA <em>TP53</em> Mutations—A Perspective from a Real-World Precision Medicine Cohort in another window
Includes: Supplementary data
Journal Articles

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

Paul Riviere, Aaron M. Goodman, Ryosuke Okamura, Donald A. Barkauskas, Theresa J. Whitchurch, Suzanna Lee, Noor Khalid, Rachel Collier, Manvita Mareboina, Garrett M. Frampton, David Fabrizio, Andrew B. Sharabi, Shumei Kato, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (10): 2139–2145.
https://doi.org/10.1158/1535-7163.MCT-20-0161
Published: 02 October 2020
View article titled, High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers
Open the PDF for High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers in another window
Includes: Supplementary data
Journal Articles

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics

In Sil Choi, Shumei Kato, Paul T. Fanta, Lawrence Leichman, Ryosuke Okamura, Victoria M. Raymond, Richard B. Lanman, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (10): 1852–1862.
https://doi.org/10.1158/1535-7163.MCT-18-0965
Published: 01 October 2019
View article titled, Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
Open the PDF for Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics in another window
Includes: Supplementary data
Journal Articles

Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis

Filip Janku, Eli L. Diamond, Aaron M. Goodman, Vaijayanthi Kandadai Raghavan, Tamara G. Barnes, Shumei Kato, Omar Abdel-Wahab, Benjamin H. Durham, Funda Meric-Bernstam, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (6): 1149–1157.
https://doi.org/10.1158/1535-7163.MCT-18-1244
Published: 03 June 2019
View article titled, Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis
Open the PDF for Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis in another window
Journal Articles

Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies

Rebecca Shatsky, Barbara A. Parker, Nam Q. Bui, Teresa Helsten, Richard B. Schwab, Sarah G Boles, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (5): 1001–1011.
https://doi.org/10.1158/1535-7163.MCT-17-1038
Published: 01 May 2019
View article titled, Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies
Open the PDF for Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients

Taylor J. Jensen, Aaron M. Goodman, Shumei Kato, Christopher K. Ellison, Gregory A. Daniels, Lisa Kim, Prachi Nakashe, Erin McCarthy, Amin R. Mazloom, Graham McLennan, Daniel S. Grosu, Mathias Ehrich, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2019) 18 (2): 448–458.
https://doi.org/10.1158/1535-7163.MCT-18-0535
Published: 04 February 2019
View article titled, Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients
Open the PDF for Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics

Sadakatsu Ikeda, Jordan S. Lim, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (5): 1114–1122.
https://doi.org/10.1158/1535-7163.MCT-17-0604
Published: 30 April 2018
View article titled, Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics
Open the PDF for Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics in another window
Includes: Supplementary data
Journal Articles

Abstract LB-A07: Clinical utility of genomic assessment of blood-derived circulating tumor (ctDNA) in patients with colorectal cancers

Maria C. Schwaederle, Shumei Kato, In Sil Choi, Paul T. Fanta, Lawrence Leichman, Scott Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): LB-A07.
https://doi.org/10.1158/1535-7163.TARG-17-LB-A07
Published: 01 January 2018
View article titled, Abstract LB-A07: Clinical utility of genomic assessment of blood-derived circulating tumor (ctDNA) in patients with colorectal cancers
Journal Articles

The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA

Paul Riviere, Paul T. Fanta, Sadakatsu Ikeda, Joel Baumgartner, Gregory M. Heestand, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1): 297–305.
https://doi.org/10.1158/1535-7163.MCT-17-0360
Published: 01 January 2018
View article titled, The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA
Open the PDF for The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA in another window
Includes: Supplementary data
Journal Articles

Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining “Actionability” of a Molecular Lesion and Patient Management Support

Young Kwang Chae, Alan P. Pan, Andrew A. Davis, Sandip P. Patel, Benedito A. Carneiro, Razelle Kurzrock, Francis J. Giles
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2645–2655.
https://doi.org/10.1158/1535-7163.MCT-17-0597
Published: 03 December 2017
View article titled, Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining “Actionability” of a Molecular Lesion and Patient Management Support
Open the PDF for Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining “Actionability” of a Molecular Lesion and Patient Management Support in another window
Journal Articles

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip P. Patel, Garrett M. Frampton, Vincent Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (11): 2598–2608.
https://doi.org/10.1158/1535-7163.MCT-17-0386
Published: 01 November 2017
View article titled, Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Open the PDF for Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers in another window
Includes: Supplementary data
Journal Articles

Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology

Hatim Husain, David Nykin, Nam Bui, Daniel Quan, German Gomez, Brian Woodward, Sumathi Venkatapathy, Radha Duttagupta, Eric Fung, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (5): 948–955.
https://doi.org/10.1158/1535-7163.MCT-16-0436
Published: 02 May 2017
View article titled, Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
Open the PDF for Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology in another window
Includes: Supplementary data
Journal Articles

Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer

Hatim Husain, Michael Scur, Ayesha Murtuza, Nam Bui, Brian Woodward, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (2): 265–272.
https://doi.org/10.1158/1535-7163.MCT-16-0105
Published: 02 February 2017
View article titled, Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer
Open the PDF for Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer in another window
Journal Articles

Genomic Landscape of Malignant Mesotheliomas

Shumei Kato, Brett N. Tomson, Timon P.H. Buys, Sheryl K. Elkin, Jennifer L. Carter, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (10): 2498–2507.
https://doi.org/10.1158/1535-7163.MCT-16-0229
Published: 02 October 2016
View article titled, Genomic Landscape of Malignant Mesotheliomas
Open the PDF for Genomic Landscape of Malignant Mesotheliomas in another window
Includes: Supplementary data